Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3Phase NA 2Phase 4 2Phase 1/2 2

Status

Completed 115Terminated 28Active not recruiting 13Withdrawn 10Recruiting 10Unknown 7Not yet recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Carcinoma, Non-Small-Cell Lung 133Breast Neoplasms 95Colorectal Neoplasms 65Carcinoma, Hepatocellular 57Squamous Cell Carcinoma of Head and Neck 48Stomach Neoplasms 46Lung Neoplasms 44Triple Negative Breast Neoplasms 43Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Small Cell Lung Carcinoma 41Uterine Cervical Neoplasms 40Rectal Neoplasms 37Neoplasms 31Pancreatic Neoplasms 30Recurrence 29Neoplasm Metastasis 29Esophageal Squamous Cell Carcinoma 25Esophageal Neoplasms 24Ovarian Neoplasms 23Nasopharyngeal Carcinoma 21Carcinoma, Renal Cell 21Brain Neoplasms 21Melanoma 20Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Endometrial Neoplasms 19Multiple Myeloma 18Head and Neck Neoplasms 18Biliary Tract Neoplasms 18

Interventions

zanubrutinib 1pirtobrutinib 1Sra protein, Drosophila 1Rituximab 1Neoadjuvant Therapy 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Waldenstrom Macroglobulinemia × Clear all
NCT07548450 2026-04-23

MPOWER

University of Utah

Phase 2 Not yet recruiting
25 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT07464210 2026-03-11

Nemtabrutinib, Bortezomib, and Rituximab for WM

Seoul National University Hospital

Phase 2 Not yet recruiting
19 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
43 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT06547866 2025-11-26

WAZABI

French Innovative Leukemia Organisation

Phase 2 Not yet recruiting
102 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡